Beryl Drugs Limited (BOM:524606)
22.25
-0.25 (-1.11%)
At close: Jan 22, 2026
Beryl Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.67 | - | - | 2.83 | 2.71 | 4.52 | Upgrade |
Short-Term Investments | - | 8.14 | 1.25 | 2.91 | 4 | 2.02 | Upgrade |
Cash & Short-Term Investments | 0.67 | 8.14 | 1.25 | 5.74 | 6.72 | 6.54 | Upgrade |
Cash Growth | -62.39% | 552.04% | -78.24% | -14.55% | 2.64% | 12.12% | Upgrade |
Accounts Receivable | 42.19 | 54.57 | 75.84 | 69 | 44.49 | 45.41 | Upgrade |
Other Receivables | - | 0.57 | 0.13 | 4.28 | 16.2 | 17.72 | Upgrade |
Receivables | 42.19 | 55.14 | 75.97 | 73.43 | 60.69 | 63.13 | Upgrade |
Inventory | 27.63 | 22.51 | 16.65 | 11.25 | 29.78 | 22.69 | Upgrade |
Prepaid Expenses | - | 0.3 | 0.27 | 0.13 | 0.33 | 0.03 | Upgrade |
Other Current Assets | 11.19 | 4.36 | 7.1 | 13.34 | 7.8 | 9.14 | Upgrade |
Total Current Assets | 81.68 | 90.45 | 101.24 | 103.89 | 105.32 | 101.52 | Upgrade |
Property, Plant & Equipment | 82.25 | 60.05 | 59.61 | 58.1 | 58.6 | 73.24 | Upgrade |
Long-Term Investments | - | - | - | 1.53 | 1.64 | 1.2 | Upgrade |
Other Intangible Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | Upgrade |
Long-Term Deferred Tax Assets | - | 0.06 | 1.03 | 1.26 | 1.86 | - | Upgrade |
Other Long-Term Assets | 10.18 | 9.04 | 12.98 | 10.32 | 10.79 | 10.48 | Upgrade |
Total Assets | 174.11 | 159.6 | 174.87 | 175.11 | 178.24 | 186.48 | Upgrade |
Accounts Payable | 18.57 | 11.16 | 20.16 | 32.48 | 30.57 | 22.2 | Upgrade |
Accrued Expenses | - | 2.33 | 2.4 | 1.91 | 1.73 | 10.1 | Upgrade |
Short-Term Debt | 27.34 | 23.64 | 26.9 | 15.88 | 33.72 | 23.54 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 2.48 | 2.47 | 7.84 | Upgrade |
Current Income Taxes Payable | 2.45 | 1.2 | 1.1 | 0.66 | - | 0.54 | Upgrade |
Current Unearned Revenue | - | 3.02 | 3 | - | - | - | Upgrade |
Other Current Liabilities | 10.1 | 1.66 | 4 | 10.02 | 16.44 | 17.92 | Upgrade |
Total Current Liabilities | 58.45 | 43 | 57.55 | 63.42 | 84.92 | 82.13 | Upgrade |
Long-Term Debt | 15.67 | 17.36 | 24.04 | 27.06 | 16.75 | 19.86 | Upgrade |
Pension & Post-Retirement Benefits | 5.23 | 4.2 | 4.04 | 3.97 | 3.63 | 3.14 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.08 | - | - | - | - | 2.05 | Upgrade |
Other Long-Term Liabilities | - | -0 | - | - | - | - | Upgrade |
Total Liabilities | 79.43 | 64.56 | 85.64 | 94.45 | 105.3 | 107.19 | Upgrade |
Common Stock | 50.94 | 50.72 | 50.72 | 50.72 | 50.72 | 50.72 | Upgrade |
Retained Earnings | - | 43.47 | 37.68 | 29.99 | 22.33 | 28.92 | Upgrade |
Comprehensive Income & Other | 43.75 | 0.86 | 0.84 | -0.05 | -0.11 | -0.34 | Upgrade |
Shareholders' Equity | 94.69 | 95.04 | 89.23 | 80.66 | 72.94 | 79.29 | Upgrade |
Total Liabilities & Equity | 174.11 | 159.6 | 174.87 | 175.11 | 178.24 | 186.48 | Upgrade |
Total Debt | 43.01 | 41 | 50.94 | 45.42 | 52.94 | 51.24 | Upgrade |
Net Cash (Debt) | -42.35 | -32.86 | -49.69 | -39.68 | -46.22 | -44.69 | Upgrade |
Net Cash Per Share | -8.40 | -6.48 | -9.80 | -7.82 | -9.11 | -8.81 | Upgrade |
Filing Date Shares Outstanding | 4.45 | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 | Upgrade |
Total Common Shares Outstanding | 4.45 | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 | Upgrade |
Working Capital | 23.23 | 47.45 | 43.68 | 40.47 | 20.4 | 19.39 | Upgrade |
Book Value Per Share | 21.28 | 18.74 | 17.59 | 15.90 | 14.38 | 15.63 | Upgrade |
Tangible Book Value | 94.68 | 95.03 | 89.22 | 80.65 | 72.91 | 79.26 | Upgrade |
Tangible Book Value Per Share | 21.28 | 18.74 | 17.59 | 15.90 | 14.38 | 15.63 | Upgrade |
Land | - | 2.55 | 2.55 | 2.55 | 2.55 | 2.55 | Upgrade |
Buildings | - | 23.92 | 23.92 | 20.47 | 21.12 | 21.57 | Upgrade |
Machinery | - | 96.51 | 88.81 | 80.21 | 72.05 | 76.01 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.